Additional information
| Active substance | Avanafil, Dapoxetine |
|---|---|
| Chemical name | 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide |
| Side effects | Headache, flushing, nasal congestion, back pain, and dizziness |
| Effects | Helps to achieve and maintain an erection |
| Dosage (sports) | Not applicable |
| Dosage (medical) | Typically 50 mg, 100 mg, or 200 mg tablets, taken as needed about 30 minutes before sexual activity |
| Half-life | Approximately 5 hours |
| Main action | Increases blood flow to particular areas of the body |
| Substance class | PDE5 inhibitor |
| Formula | C23H26ClN7O3 |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Trade name | Stendra, Spedra |
| Blood pressure | Can cause a decrease in blood pressure |
| Also known as | TA-1790 |
| Strength | 100/60 mg |
| Lab Test | Not specified |
| Hepatotoxicity | Low risk |
| Water Retention | No significant effect |
| Use in sports | Not typically used in sports |
| Manufacturer | Sunrise Remedies Pvt. Ltd. |
| Packing | 4 tabs/blister |
